{"id":"W2100797437","doi":"10.1056/nejmoa0806104","title":"Telaprevir with Peginterferon and Ribavirin for Chronic HCV Genotype 1 Infection","year":2009,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1087,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Valeant Pharmaceuticals International; Vertex Pharmaceuticals; Duke Clinical Research Institute; Gilead Sciences","keywords":"Telaprevir; Ribavirin; Medicine; Virology; Hepatitis C virus; Genotype; Protease inhibitor (pharmacology); Chronic hepatitis; Hepacivirus; Virus; Boceprevir; Pegylated interferon; Immunology; Viral load; Biology; Gene","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null}